Similar articles

• Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.

  Hansen LB, Larsen NE. Hansen LB, et al. Psychopharmacology (Berl). 1977 Jul 18;53(2):127-30. doi: 10.1007/BF00426481. Psychopharmacology (Berl). 1977. PMID: 408838
• Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.

  Fann WE, Linton PH. Fann WE, et al. Curr Ther Res Clin Exp. 1972 Aug;14(8):478-82. Curr Ther Res Clin Exp. 1972. PMID: 4629310 No abstract available.
• The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.

  Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB Jr. Mazure CM, et al. J Clin Psychiatry. 1990 Aug;51(8):330-4. J Clin Psychiatry. 1990. PMID: 2199431 Clinical Trial.
• [Pharmacological treatment of delusional depression].

  Amore M, Giordani L, Giorgetti G, Zazzeri N. Amore M, et al. Minerva Psichiatr. 1996 Mar;37(1):29-33. Minerva Psichiatr. 1996. PMID: 8804200 Review. Italian.
• II. Major tranquilizers.

  Kehoe MJ. Kehoe MJ. South Med J. 1971 Apr;64(4):403-10. doi: 10.1097/00007611-197104000-00005. South Med J. 1971. PMID: 4930514 Review. No abstract available.